ÂÜÀòÂÒÂ×

Ben Tehan has worked in the biotech industry since 2003. Ben began their career at the Victorian Infectious Disease Research Laboratory as a Computational Chemist. In 2003, they joined GlaxoSmithKline as an Investigator. In 2010, they moved to Heptares as an Associate Director. Since 2019, they have been a Senior Director at OMass Therapeutics.

Ben Tehan completed their PhD in Pharmacy and Medicinal Chemistry at Monash University from 1999 to 2003. Ben then obtained their BSc (Hons) in Chemistry from Swinburne University of Technology from 1993 to 1998.